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documented.
RESULTS Of 65 patients, 52 cases were through the transradial
approach and 13 cases through the femoral artery. There were 40 cases
of the CTO lesions, 10 cases of the bifurcation lesionss, 6 cases of
severely calciﬁed lesions, and 9 cases of the seriously tortuosity of the
coronary artery. In this case, positive guide wire was used with con-
ventional methods in all patients, but failed to cross the coronary
lesions. So the 135 cm Corsair microcatheter was applied. Of CTO le-
sions in 40 cases, after the application of Corsair microcatheter, pos-
itive guide wire crossed the CTO lesions in 33 patients and success
recanalization of CTO were ﬁnally achieved in 29 (72.5%) patients. The
success rate for crossing the bifurcation lesions by the Corsair
microcatheter was 90% in 9 out of 10 patients and PCI was success
ﬁnally in 9 (90%) patients.
Of 6 cases of severely calciﬁed lesions, guide wire crossed the
lesion in 5 patients after the application of Corsair microcatheter
and PCI was success in 6 (100%) patients. Of 9 cases of the seri-
ously tortuosity of the coronary artery, guide wire crossed the
lesion in 9 patients after the application of Corsair microcatheter
and PCI was success in 9 (100%) patients. There was no complica-
tions related to Corsair microcatheter during the index procedure,
no major adverse cardiac events during in-hospital clinical follow-
up.
CONCLUSIONS Corsair microcatheter is safe and effective in the
recanalization for complex coronary lesions when guide wire with
conventional methods could not cross them. It can facilitate guide-
wire passage and increase the success rate of PCI.
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Prognosis of Anti-Helicobacter Pylori Treatment and Acute Coronary
Syndrome
Jin Hou
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OBJECTIVES To investigate Prognosis of Anti-Helicobacter Pylori
Treatment and Acute Coronary Syndrome, to provide a reference for
future treatment.
METHODS We selected 200 patients with acute coronary syndrome
who were treated in our hospital during October 2011 - October 2013,
and divided into the Control Group and the Observation Group by the
treatment. The Control Group was received conventional therapy,
while the Observation Group was received treatment with
Omeprazole þ clarithromycin þ amoxicillin. Then compared and
analyzed the clinical effect of the both of groups, at the same time,
counted the number of cases of coronary recurrence.
RESULTS The total efﬁciency after treatment, CHD events followed
up six months later, readmission rates, mental function, physical
function, social function, physical status and quality of life of both of
groups have been compared. As a result, the difference between the
two groups showed statistically signiﬁcant, P <0.05. 13 cases out of
the Observation Group occurred adverse reactions during the treat-
ment, all of patients tolerated and the symptoms disappeared after
treatment.
CONCLUSIONS Eradication of H. pylori can improve treatment effect
of patient with acute coronary syndrome, reduce hospitalization rates
in patients in the short term, and hence has a good improvement on
the prognosis of the disease.
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OBJECTIVES Previous studies demonstrated that elevated remnant
cholesterol (RC) was a useful predictor of cardiovascular disease. Pa-
tients with type 2 diabetes (T2D) following percutaneous coronary
intervention (PCI) had worse prognosis, especially in poorly-
controlled T2D. However, whether RC was associated with peri-
procedural myocardial injury (PMI) following PCI in patients with T2D
is currently unknown. This study tried to explore the association ofpreprocedural RC and the ratio of RC to HDL cholesterol (RC/HDL-C)
levels with peak cTnI values after PCI in patients with T2D.
METHODS We prospectively enrolled 1182 consecutive T2D patients
with normal preprocedural cTnI undergoing PCI. Patients were
divided into the two groups: group A [glycated hemoglobin
(HbA1c) <7%, n¼563] and group B (HbA1c 7%, n¼619). PMI was
evaluated by cTnI analysis within 24h.
RESULTS Patients in group B, a 1-SD increase in RC produced a 32%
increased risk of postprocedural cTnI >3 upper limit of normal (ULN)
or >5 ULN. For RC/HDL-C, the causal odds ratio was 1.49 (95% conﬁ-
dence interval [CI]: 1.12 to 1.99) and 1.51 (95% CI: 1.13 to 2.01) in group B
with postprocedural cTnI >3 ULN and >5 ULN, respectively.
However, group A patients were no affected. Furthermore, patients
with RC levels >27.46 mg/dl (third tertile) compared with RC
levels 14.15 mg/dl (ﬁrst tertile) were associated with a 59% and 96%
increased risk of postprocedural cTnI > 3 ULN and >5 ULN in group
B, respectively.
CONCLUSIONS RC and RC/HDL-C are the valuable, independent pre-
dictors for PMI in poorly-controlled diabetic patients undergoing PCI.
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OBJECTIVES Postoperative anemia (PPA) is a common complication
after the coronary artery bypass surgery (CABG). Since the blood
transfusion was not suggested in the updated clinical guideline, PPA
would be more prevalent. Whether PPA leaded to poor exercise ca-
pacity recovery in CABG patients after their discharge was still un-
clear. The purpose of this study was to explore the impact of
postoperative anemia on exercise capacity in patients underwent
CABG.
METHODS This is an observational cohort study. Patients underwent
CABG from Jan. to Dec. 2014 and completed cardiopulmonary exercise
test (CPX) after discharge were included. Those who have had anemia
before operation were excluded. Based on the last concentration of
hemoglobin (Hb) data before discharge subjects’ Hb <11 g/dL were
deﬁned as severe group. The others did not have signiﬁcant low Hb
data, Hb S11 g/dL, were mild group. Subjects received CPX at
discharge and three months after discharge. Exercise capacity, rep-
resented by peak oxygen consumption (VO2), and exercise responses,
including heart rate (HR), blood pressure (BP), oxygen pulse (O2
pulse), dead space (VD/VT) and ventilation (VE) were acquired from
CPX. T-test and Chi-square were used to compare the baseline de-
mographic data. Two-way RM-ANOVA was used to compare the ex-
ercise capacity recovery through time and between groups. The
signiﬁcant level was set at p<0.05.
RESULTS Thirty-seven subjects (73.0% male, 64.17.6 year-old)
were included for analysis. The Hb ranged from 8.3 to 12.6 g/dL
(mean value 10.61.2 g/dL). There were 16 (43.2%) patients in mild
group; 21(56.8%) in severe group. The exercise capacity of both
groups had signiﬁcantly improvement through time (p¼0.001), and
no signiﬁcant difference between groups (p¼0.616). The VO2 value
at 3 months after discharge of mild and severe group were 23.36.1
and 20.95.8 ml/Kg/min, respectively. Both groups showed better
exercise performance at 3 months after discharge, suggested of
higher peak HR (p¼0.006), higher peak systolic BP (p¼0.033) and
lower VD/VT (p¼0.008). The improvements showed no signiﬁcant
difference between 2 groups.
CONCLUSIONS Postoperative anemia during hospitalization had no
notable impact on the exercise capacity recovery in patients under-
went CABG. Subjects even had moderate or severe anemia would have
equivalent improvement at 3 months after discharge.
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OBJECTIVES To evaluate the clinical efﬁcacy and security of small-
diameter balloon at side branch in dealing with coronary bifurcation
lesions.
